Shopping Cart
- Remove All
Your shopping cart is currently empty
COE-PNH2 exhibits antibacterial activity against Mycobacterium abscessus (Mab) with an MIC90 of 26 μM. It disrupts bacterial cell wall and membrane integrity, possesses intracellular permeability, and lacks mitochondrial toxicity.

| Description | COE-PNH2 exhibits antibacterial activity against Mycobacterium abscessus (Mab) with an MIC90 of 26 μM. It disrupts bacterial cell wall and membrane integrity, possesses intracellular permeability, and lacks mitochondrial toxicity. |
| In vitro | COE-PNH2 (0-128 μg/mL) demonstrates stable antibacterial activity against intracellular, replicative, and nutrient-deprived Mycobacterium abscessus (Mab) strains with exceptionally high antibiotic tolerance. It exhibits a low propensity for resistance development, maintaining consistent minimum inhibitory concentration (MIC) values over 14 consecutive Mab passages. At concentrations ranging from 0-64 μg/mL, COE-PNH2 induces ATP depletion, intracellular lipid inclusions (ILIs) accumulation, and bacterial elongation in Mab. |
| In vivo | COE-PNH2 (2.5-5 mg/kg, administered intratracheally every two days for a total of 12 days) demonstrated good tolerability and efficacy in C3HeB/FeJ mice with acute lung infections. |
| Formula | C54H98Cl8N8O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.